Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Dana Incorporated announces Gajanan Gandhe as country leader of Dana India May 6, 2019 Zaber introduces X-GSR-E Series motorized goniometers March 25, 2019 Bharat QR code to be introduced on mobile POS devices soon May 31, 2017